Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS)...
ArisGlobal Receives Frost & Sullivan’s 2025 Global Intelligent MedDRA Coding New Product Innovation Recognition for AI Leadership and Customer Impact
ArisGlobal is honored for its technological breakthrough in intelligent MedDRA coding that enhances accuracy, accelerates compliance workflows, and advances innovation in pharmacovigilance. SAN ANTONIO, Oct. 23, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that ArisGlobal has received the 2025 Global New Product Innovation Recognition in the intelligent MedDRA Coding industry for its outstanding achievements in innovation, customer impact, and...
HanchorBio’s Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology
Prestigious peer-review validates HCB101's differentiated mechanism and translational strength. Clinical data show a nearly 90% partial response rate in 2L gastric cancer (combo) and safe escalation to 30 mg/kg (mono) TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 23, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company developing next-generation immunotherapies, today announced that its...
Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific
With a strong track record across APAC, Francis Wan's appointment marks a powerful acceleration of Medison's growth in the region ZUG, Switzerland, Oct. 23, 2025 /PRNewswire/ -- Medison, the creator of a first-of-its-kind unified global commercialization platform for breakthrough therapies, today announced the appointment of Francis Wan as VP, GM Asia Pacific...
TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today welcomes updated guidelines from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Nuclear Medicine (EANM) and The American College of Nuclear Medicine (ACNM) that, for the first time, include the...
International Youth Explore the Wisdom of Traditional Chinese Medicine Zhangshu National Pharma Fair Opens a New Chapter in Cultural Experience
ZHANGSHU, China, Oct. 23, 2025 /PRNewswire/ -- A report from Jiangxi International Communication Center (JXICC): "Without Zhangshu, medicines are incomplete; without Zhangshu, medicines lack efficacy." On October 16, 2025, Jiangxi's Zhangshu Qihuang Town was bustling with crowds as the 56th National Medicinal Materials and Pharmaceuticals Trade Fair grandly opened here. Simultaneously, an international youth exploration journey in Jiangxi, themed "From Ancient Wisdom to...
1doc Academy and Kingston International College Partner to Strengthen Singapore’s Healthcare Workforce through Applied Learning and Digital Innovation
SINGAPORE, Oct. 23, 2025 /PRNewswire/ -- 1doc Academy, the training arm of iAPPS Health Group (1doc) and Kingston International College (KIC) formalised their partnership with the signing of an agreement at GovWare 2025 on 22 October. The ceremony was witnessed by Senior Minister of State Tan Kiat How, Ministry of Health and Ministry of Digital Development and Information. The...
MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring
SÃO PAULO, Oct. 23, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing essential tools and technologies to drive innovation in the life sciences, has entered into a strategic partnership with Eva Holding Group, a Brazilian group operating in genomics applied to human health, animal health, and agribusiness. The initiative aims...
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease
TAIPEI, Oct. 23, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for AJ201, the first-in-class for therapy for spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease). "Receiving the Fast Track Designation for AJ201 marks a significant milestone for...
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain associated with bone metastasis. TLX090 is designed to deliver targeted...
